Hence a focused approach using HBeAg status, age, ethnic origin with longitudinal assessment of LFTs and viral load should be studied in patients with “normal ALT” at the upper end of normal range (ALT 20–40 IU/L) to appropriately classify patients and select patients that require an assessment of liver fibrosis to inform treatment decisions. Here, GPT is linked to Hepatic fibrosis.